Myo Rapid Quantitative Test
- UID
- IMP/IVD/2021/000395_5402c1da55540d1cb9c6be8c83a04c00_896dedf7e9c64dc5716c303d961519b2
- Device class
- Class B
- Brand name
- Biotime
- License holder
- M/s Vishat Diagnostic Pvt Ltd.
- Approving authority
- CDSCO
- Product information
- The Biotime MYO (Biotime ) Rapid Quantitative Test is intended to quantify the concentration of MYO in human serum or plasma on Biotime FIA Analyzers by fluorescent immunoassay. It is used as an aid detection of acute myocardial infarction
Myo Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000395_5402c1da55540d1cb9c6be8c83a04c00_896dedf7e9c64dc5716c303d961519b2. This device is marketed under the brand name Biotime . The license holder is M/s Vishat Diagnostic Pvt Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.